Novartis is making another pact in radiopharma, promising as much as $745 million to a Boston-based startup.
Ratio Therapeutics will get an undisclosed upfront payment …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.